Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disorder, typically driven by PKD1 and PKD2 variants. Recent reports implicate monoallelic loss-of-function variants in IFT140 as a rare cause of ADPKD (PMID:39015124; PMID:37844724). This summary evaluates the genetic and experimental evidence supporting a definitive gene–disease relationship between IFT140 and Autosomal Dominant Polycystic Kidney Disease.
Genetic evidence derives from multiple cohorts: six unrelated probands with heterozygous IFT140 frameshift variants presented with renal cysts and hypertension (PMID:37844724), 14 index cases harboring distinct IFT140 loss-of-function alleles in a 218-patient cystic nephropathy cohort (PMID:40428294), and a case series of 75 individuals from 61 families with monoallelic predicted LoF IFT140 variants (PMID:39732359). Segregation analysis across these studies identified 14 additional affected relatives, confirming autosomal dominant inheritance and co-segregation of IFT140 alleles. A representative variant is c.1377G>A (p.Trp459Ter).
The variant spectrum in ADPKD-IFT140 includes predominantly protein-truncating changes: 122 unique LoF alleles comprising 46% frameshift, 31% nonsense, 18% splice-site, and 5% exon-level deletions (PMID:39136524). A recurrent exon-13 deletion was also observed in a pediatric case and mother pair (PMID:39015124). No founder alleles have been defined, consistent with the broad allelic heterogeneity.
Functional studies support haploinsufficiency as the likely pathogenic mechanism. Affinity purification–mass spectrometry demonstrated that a subset of IFT140 missense mutations reduces IFT-A complex interactions in vitro, indicating compromised ciliary transport (PMID:39880085). Patient-derived renal epithelial cells harboring LoF IFT140 variants accumulate IFT88 at ciliary tips, reflecting retrograde trafficking defects (PMID:30479745). These cellular phenotypes parallel cystic changes in human carriers.
Clinically, ADPKD-IFT140 patients exhibit atypical bilateral kidney cysts with large exophytic lesions, limited liver involvement, mild proteinuria (HP:0012595) and hypertension (HP:0000822), and occasional hyperuricemia (HP:0002149) (PMID:40428294). Most maintain preserved glomerular filtration with rare progression to end-stage kidney disease (HP:0003774). Estimated genetic prevalence is 19.8–27.9 per 10,000 in population databases (PMID:39732359).
No conflicting reports dispute the association. Given replication across >368 probands, segregation in multiple families, and concordant functional assays, the IFT140–ADPKD link meets criteria for a Definitive ClinGen gene–disease classification. IFT140 should be included in ADPKD testing panels to improve diagnosis and guide management. Key Take-home: Monoallelic IFT140 loss-of-function variants cause a mild, atypical form of ADPKD with favorable prognosis, warranting targeted genetic screening.
Gene–Disease AssociationDefinitiveReplicated in >368 probands across multiple independent cohorts, segregation in 14 relatives, and concordant functional data Genetic EvidenceStrongMonoallelic IFT140 LoF variants in 75 families, 14 index cases in a panel study, and six additional probands confirm AD inheritance ([PMID:39732359]; [PMID:40428294]; [PMID:37844724]) Functional EvidenceModerateAP-MS and patient cell assays demonstrate IFT-A complex disruption and retrograde ciliary trafficking defects consistent with human phenotypes ([PMID:39880085]; [PMID:30479745]) |